Please assess the completion status of the following clinical trial:

Trial Title: Treatments for Depression: Drug Versus Psychotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~* Major Depressive Disorder diagnosis~Exclusion criteria:~* Psychotic or bipolar disorder diagnosis~* Substance dependence in the last 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 Sertraline/Venlafaxine (Type: EXPERIMENTAL): Participants receive sertraline for the first 8 weeks. Participants will receive venlafaxine if they do not respond to sertraline by week 8
- 2 Supportive Expressive Therapy (Type: ACTIVE_COMPARATOR): Participants will receive supportive-expressive psychotherapy.
- 3 Pill Placebo (Type: PLACEBO_COMPARATOR): Participants receive placebo.

Based on this trial design, predict the completion outcome and termination type (if applicable).